Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $1.0 million.

  • Sanara MedTech's Depreciation & Amortization (CF) fell 588.18% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 1080.49%. This contributed to the annual value of $4.9 million for FY2024, which is 3396.43% up from last year.
  • Sanara MedTech's Depreciation & Amortization (CF) amounted to $1.0 million in Q3 2025, which was down 588.18% from $1.1 million recorded in Q2 2025.
  • Sanara MedTech's Depreciation & Amortization (CF)'s 5-year high stood at $1.6 million during Q4 2024, with a 5-year trough of $90591.0 in Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $814881.0 (2022), whereas its average is $781255.9.
  • As far as peak fluctuations go, Sanara MedTech's Depreciation & Amortization (CF) surged by 43480.81% in 2022, and later plummeted by 588.18% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Depreciation & Amortization (CF) stood at $201007.0 in 2021, then surged by 305.12% to $814316.0 in 2022, then skyrocketed by 34.44% to $1.1 million in 2023, then skyrocketed by 46.92% to $1.6 million in 2024, then tumbled by 35.41% to $1.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $1.0 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.